KLARSEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.1 EUR | -5.62% |
|
-5.41% | -22.79% |
| 03-15 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
| 2023 | Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KLARSEN | Other IT Services & Consulting | -5.62% | -5.41% | -22.79% | -19.54% | +1,120.93% | 7.55M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALKLA Stock
- Charts Klarsen
- Comparison Chart
